Related Experiment Videos
Synthetic or natural surfactants
1Regional Neonatal Unit, Royal Maternity Hospital, Belfast, UK.
Acta Paediatrica (Oslo, Norway : 1992)
|March 1, 1997
Summary
Surfactant replacement therapy significantly reduces neonatal mortality and pulmonary air leaks in premature infants. Early administration and natural surfactant preparations offer the greatest benefits, with no substantiated safety concerns.
Area of Science:
- Neonatal Medicine
- Pulmonology
- Pediatric Critical Care
Background:
- Surfactant replacement therapy (SRT) is a cornerstone in managing respiratory distress syndrome (RDS) in neonates.
- Extensive randomized clinical trials (RCTs) support SRT's efficacy in reducing mortality and air leaks.
- Despite established benefits, questions persist regarding optimal timing and specific surfactant types.
Purpose of the Study:
- To review the established benefits and lingering questions surrounding surfactant replacement therapy in neonatal medicine.
- To evaluate the comparative efficacy of natural versus synthetic surfactant preparations.
- To assess safety concerns and long-term outcomes associated with SRT.
Main Methods:
- Systematic review of numerous randomized clinical trials involving surfactant therapy in neonates.
- Analysis of data on neonatal mortality, pulmonary air leaks, and other clinical outcomes.
- Evaluation of safety data regarding immunological effects, prion transmission, and contamination.
Main Results:
- SRT demonstrably reduces neonatal mortality and the incidence of pulmonary air leaks in infants with or at risk for RDS.
- Earlier administration, particularly prophylactic treatment for extremely preterm infants (<28 weeks gestation), yields superior outcomes.
- Natural surfactant preparations containing proteins B and C show faster action and potentially greater efficacy than protein-free synthetic versions.
- Concerns regarding immunological effects, prion transmission, and contamination of natural surfactants are unsubstantiated.
- Long-term follow-up reveals no significant differences in overall outcomes, though natural surfactant may reduce retinopathy of prematurity.
Conclusions:
- Surfactant replacement therapy is a safe and effective intervention for respiratory distress syndrome in neonates.
- Early and natural surfactant administration provides the most significant clinical benefits.
- Further research is warranted to explore newer surfactant preparations and expanded indications.